Last reviewed · How we verify

NCT03591588

Effects of Diet Interventions on Monocytes in Metabolic Syndrome

Completed NA Last updated 8 July 2020
What this trial tests

NA trial testing diet in Metabolic Syndrome in 20 participants. Completed in 31 March 2020.

Timeline
1 April 2016
Primary endpoint
31 March 2020
31 March 2020

Quick facts

Lead sponsorBaylor College of Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment20
Start date1 April 2016
Primary completion31 March 2020
Estimated completion31 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor College of Medicine

Who can join

Adults 21 to 75, any sex, with Metabolic Syndrome or Hypertriglyceridemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subjects with hypertriglyceridemia and metabolic syndrome are being recruited and receive diet interventions with either a high-saturated fat diet or a low-fat high protein diet for 4 days (days 1-4) and a breakfast on day 5. Blood samples are collected on day 1 and day 5 to examine lipid levels and circulating monocyte phenotypes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of diet

Trials testing the same drug.

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

Other Baylor College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03591588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing